Novelion Therapeutics Inc. (NVLN) dipped -9.38% or -0.12 to $1.16. It is nearly 540741 shares traded, which is 13.68% compare to the average total volume 3.95 million. The market cap of NVLN is $21.53 million. The year to date change is -70.94%. The 52 week price range is from $0.7 to $5.87. Price of NVLN have changed 38.44% during last week. It have changed 54.91% over last month, -67.35% over last 3 months, -66.32% over last 6 months and -66.23% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 1.33. It is 14.66% above current price. The 200-day Moving Averages for NVLN is 3.24. It is 179.31% above current price. The 52-week High is 5.87. It is 406.03% from the current price. The 52-week Low is 0.7. It is -39.66% from current price.
There are some statistics of NVLN. It is has market cap $21.53 million. The share outstanding is 18.56 million. The average volume is 3.95 million. The percent of top 15 Institution holding is 97.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is 733.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -30.95%.